Gene · 6659
Papers4,583
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,583
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing Molecular Insights for Translational Impact: Highlights from the Special Issue Titled "New Insights in Translational Bioinformatics". | Int J Mol Sci | 2025 | 39859295 | PubTator, text mining | PubMed |
| O-GlcNAcylated FTO promotes m6A modification of SOX4 to enhance MDS/AML cell proliferation. | Cell Commun Signal | 2025 | 39849461 | PubTator, text mining | PubMed |
| Specification of claustro-amygdalar and palaeocortical neurons and circuits. | Nature | 2025 | 39814878 | PubTator, text mining | PubMed |
| Chromatin landscape alteration uncovers multiple transcriptional circuits during memory CD8+ T-cell differentiation. | Protein Cell | 2025 | 39804040 | PubTator, text mining | PubMed |
| Vitamin D receptor regulates methyltransferase like 14 to mitigate colitis-associated colorectal cancer. | J Genet Genomics | 2025 | 39778713 | PubTator, text mining | PubMed |
| A cutting-edge investigation of the multifaceted role of SOX family genes in cancer pathogenesis through the modulation of various signaling pathways. | Funct Integr Genomics | 2025 | 39753912 | PubTator, text mining | PubMed |
Retraction notice to "Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma" [Auris Nasus Larynx 48 (2021) 1167-1175]. | Auris Nasus Larynx | 2025 | 39709785 | PubTator, text mining | PubMed |
| Identifying potential active ingredients from pomegranate in treating anemia: CPA3 and SOX4 are key proteins. | Int J Biol Macromol | 2025 | 39608521 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis identifies subclusters and signature with N-glycosylation in endometrial cancer. | Clin Transl Oncol | 2025 | 39589706 | PubTator, text mining | PubMed |
| Long Non-coding RNA FOXD2-AS1 Silencing Inhibits Malignant Behaviors of Ovarian Cancer Cells Via miR-324-3p/SOX4 Signaling Axis. | Reprod Sci | 2025 | 39455487 | PubTator, text mining | PubMed |
| SOX4 facilitates brown fat development and maintenance through EBF2-mediated thermogenic gene program in mice. | Cell Death Differ | 2025 | 39402212 | PubTator, text mining | PubMed |
| scooby: Modeling multi-modal genomic profiles from DNA sequence at single-cell resolution. | bioRxiv | 2025 | 39345504 | PubTator, text mining | PubMed |
| Knockdown of hsa_circ_0102231 Impedes the Progression of Liver Cancer through the miR-873-SOX4 Axis. | Curr Gene Ther | 2025 | 38963113 | PubTator, text mining | PubMed |
| Brevilin A Inhibits Prostate Cancer Progression by Decreasing PAX5-Activated SOX4. | Mol Biotechnol | 2025 | 38744788 | PubTator, text mining | PubMed |
| Cell state plasticity in neuroblastoma. | EJC Paediatr Oncol | 2024 | 40831912 | PubTator, text mining | PubMed |
| The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression. | Front Immunol | 2024 | 39963655 | PubTator, text mining | PubMed |
| Identification and validation of glycolysis-related diagnostic signatures in diabetic nephropathy: a study based on integrative machine learning and single-cell sequence. | Front Immunol | 2024 | 39916957 | PubTator, text mining | PubMed |
| Genomic tumor evolution dictates human medulloblastoma progression. | Neurooncol Adv | 2024 | 39659836 | PubTator, text mining | PubMed |
| Comparative study of the three-dimensional genomes of granulosa cells in germinal vesicle and metaphase II follicles. | Front Genet | 2024 | 39634272 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6659/papers?page=11